AstraZeneca PLC
XBER:ZEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AstraZeneca PLC
XBER:ZEG
|
UK |
|
M
|
Metro Inc
OTC:MTRAF
|
CA |
|
N
|
Nippon Television Holdings Inc
TSE:9404
|
JP |
|
C
|
Coterra Energy Inc
XMUN:XCQ
|
US |
|
Newegg Commerce Inc
F:J8D0
|
US |
|
I
|
Ionis Pharmaceuticals Inc
SWB:ISI
|
US |
|
R
|
Ryanair Holdings PLC
OTC:RYAOF
|
IE |
|
S
|
Sartorius AG
DUS:SRT3
|
DE |
|
Grifols SA
LSE:0RDV
|
ES |
Wall St Price Targets
ZEG Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for ZEG is 201.82 EUR with a low forecast of 131.28 EUR and a high forecast of 350.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZEG's stock price target?
Price Target
201.82
EUR
According to Wall Street analysts, the average 1-year price target for ZEG is 201.82 EUR with a low forecast of 131.28 EUR and a high forecast of 350.25 EUR.
What is the Revenue forecast for AstraZeneca PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for AstraZeneca PLC?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 13%.
What is the Net Income forecast for AstraZeneca PLC?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 13%.
